Keyphrases
Proliferative Vitreoretinopathy
100%
Intravitreal Triamcinolone
100%
Visual Acuity
84%
Lens Status
73%
Macular Edema
72%
Retinal Vein Occlusion
66%
Triamcinolone Injection
66%
Intraocular Pressure
58%
Phakic
56%
Retinal Thickness
45%
Intravitreal Ranibizumab
41%
Proliferative Diabetic Retinopathy
40%
Multiple Injections
40%
Epiretinal Membrane
36%
Cataract
36%
Anatomic Success
35%
Silicone Oil
35%
Retinal Diseases
33%
Anti-VEGF Therapy
33%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
33%
Surgical Outcomes
33%
Diabetic Vitrectomy
33%
Neovascular Age-related Macular Degeneration (nAMD)
33%
Receptor for Advanced Glycation End Products
33%
Anti-vascular Endothelial Growth Factor Therapy
33%
Branch Retinal Vein Occlusion
33%
Increased Intraocular Pressure
33%
Ocular Coherence Tomography
33%
Scleral
33%
Visual Outcome
33%
High Myopia
33%
Macular Telangiectasia Type 2
33%
Optical Coherence Tomography
31%
Recurrent Retinal Detachment
26%
Phakic Eye
26%
Posterior Capsular Opacification
26%
Intraocular Pressure Elevation
25%
Hypotonia
25%
Tamponade
24%
Vitrectomy
24%
Lens Implantation
20%
Diopter
20%
Refractive Error
20%
Five Eyes
18%
Intraocular Implant
16%
Scleral Thickness
16%
Central Foveal Thickness
16%
Cataract Extraction
16%
Follow-up Time
16%
Amphoterin
14%
Medicine and Dentistry
Triamcinolone
100%
Proliferative Vitreoretinopathy
100%
Visual Acuity
98%
Macular Edema
72%
Intraocular Pressure
66%
Central Retinal Vein Occlusion
66%
Retinotomy
66%
Vitrectomy
47%
Retinal Detachment
40%
Proliferative Diabetic Retinopathy
40%
Silicone Oil
37%
Tamponade
37%
Epiretinal Membrane
37%
Cataract
37%
Ranibizumab
36%
Coherence
33%
Vitreous
33%
Upregulation
33%
Wet Macular Degeneration
33%
Tomography
33%
Retina Disease
33%
High Myopia
33%
Advanced Glycation End Product Receptor
33%
Telangiectasia
33%
Endothelial Cell Growth Factor
33%
Branch Retinal Vein Occlusion
33%
Prospective Study
33%
Hemiretinal Vein Occlusion
33%
Optical Coherence Tomography
27%
Subcapsular Cataract
26%
Vasculotropin
21%
Refractive Error
20%
High Mobility Group B1 Protein
18%
Cataract Surgery
17%
Advanced Glycation End-Product
14%
Reoperation
14%
Diabetes Mellitus
13%
Fluorescein Angiography
12%
Intravitreal Administration
12%
Calgranulin
11%
Sclera
11%
Fluorocarbon
10%
Surgery
10%
Glaucoma
10%
Triamcinolone Acetonide
10%
Ocular Hypertension
10%
Postoperative Complication
9%
Peroperative Complication
9%
Aphakia
8%
Implant
8%